DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p9nxp7/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the US Physician Office and Group Practice Diagnostic Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities" report to their offering.
This 970-page report provides comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
This report will help diagnostic reagent and instrument suppliers develop more effective business, R&D and marketing strategies.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of the physician office/group practice diagnostics market, including its dynamics, trends, structure, size, growth and major suppliers.
Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures, including:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Flow Cytometry
- Drugs of Abuse
- Endocrine Function
- Tumor Markers
- ADI/American Diagnostica
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Decode Genetics
- Diagnostica Stago/Trinity Biotech
- Eiken Chemical
- EKF Diagnostics
- Helena Laboratories
- Instrumentation Laboratory
- International Technidyne/Nexus DX
For more information visit http://www.researchandmarkets.com/research/p9nxp7/2016_future